Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Oxonica PLC Shareholders‚ Action Group has been formed

Abstract:
The Oxonica Shareholders‚ Action Group has been formed to represent the interests of private investors in Oxonica PLC

Oxonica PLC Shareholders‚ Action Group has been formed

London, UK | Posted on June 18th, 2008

It was announced today that The Oxonica Shareholders‚ Action Group (OXONSAG, www.oxonsag.com) has been formed to represent the interests of private investors who have lost money as a result of an investment in Oxonica PLC.

Oxonica PLC is listed on the Alternative Investment Market (AIM) and it‚s chairman is Richard Farleigh, one of Oxonica's largest investors and a former panelist on BBC TV's Dragon's Den. Other large shareholders include BASF Venture Capital, Foresight Technology VCT, Alavita, Inc & Stagecoach Bus Holdings Limited

####

About Oxonica Shareholder's Action Group
OXONSAG is particularly concerned about the lack of information given to shareholders over the last two years. This is set out in some detail on their website (www.oxonsag.com) but, briefly, it appears that the shareholders were being encouraged to buy shares in Oxonica despite the fact that a crucial supply agreement with Petrol Ofisi was far from secure and despite the fact that the company was embroiled in a legal dispute with Neuftec Limited, which ended up going to trial in early June 2008.

OXONSAG is open to any shareholder, past or present, who wishes to examine the legal and regulatory routes available to limit and recover the losses that they have suffered.

OXONSAG has been overwhelmed by pledges of support from private shareholders for the idea of forming one group which can act quickly and talk as one.

Our first objective is to collate a group of shareholders (10% minimum) that will call an Extraordinary General Meeting pursuant to sections 303 & 304 of the Companies Act 2006, to discuss the removal of the board and to find a suitable replacement.

Legal Counsel will be announced shortly to explore the various legal & regulatory remedies available to OXONSAG.

For more information, please click here

Contacts:
(PO Box) BM OXONSAG
London
WC1N 3XX
England

Copyright © Oxonica Shareholder's Action Group

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Legal

180 Degree Capital Corp. Issues Open Letter to the Board and Shareholders of Enzo Biochem, Inc. February 4th, 2021

Nanogate: Meeting of creditors on November 4, 2020 September 4th, 2020

GLOBALFOUNDRIES Files Patent Infringement Lawsuits Against TSMC In the U.S. and Germany: Injunctions seek to prevent unlawful importation of infringing Taiwanese semiconductors August 26th, 2019

SUNY CNSE and Albany Law School Partner to Create First-of-its-Kind Nanotechnology Education and Training Program November 5th, 2013

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Energy

KAIST researchers introduce new and improved, next-generation perovskite solar cell​ November 8th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Groundbreaking precision in single-molecule optoelectronics August 16th, 2024

Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project